Ho­mol­o­gy sails with same cap­tains in dif­fer­ent seats; Ex-Har­poon chief weath­ers the Storm at UK biotech

Af­ter a mul­ti-year run as co-work­ers at Shire Phar­ma­ceu­ti­cals, Arthur Tzian­a­bos and Al­bert Sey­mour got the band back to­geth­er in 2016 as two of the ear­ly-days em­ploy­ees at Ho­mol­o­gy Med­i­cines.

Tzian­a­bos as CEO and Sey­mour as sci­ence chief of the ge­net­ic med­i­cine-fo­cused biotech “was not re­al­ly ready for prime time,” in the words of Sey­mour. The plan from the start was to have Sey­mour as­sume the chief ex­ec­u­tive du­ties once the biotech was ful­ly in the clin­ic with mul­ti­ple pro­grams to ac­count for.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.